about
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidat...
Read More
19.60
-0.40
(-2.00%)
48,774
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Surrozen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..